Calorie restriction is a major determinant of the short-term metabolic effects of gastric bypass surgery in obese type 2 diabetic patients

Clinical Endocrinology

Volumn 80, Issue 6, 2014, Pages 834-842

  Lips, Mirjam A ^a   De Groot, Gerrit H ^b   Van Klinken, Jan B ^a   Aarts, Edo ^c   Berends, Frits J ^c   Janssen, Ignace M ^c   Van Ramshorst, Bert ^d   Van Wagensveld, Bart A ^e   Swank, Dingeman J ^f   Van Dielen, Francois ^f   Willems Van Dijk, Ko ^g   Pijl, Hanno ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RED CROSS HOSPITAL   (Netherlands)

^c Department of Surgery Rijnstate Ziekenhuis   (Netherlands)

^d ST ANTONIUS HOSPITAL   (Netherlands)

^e ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^f Nederlandse Obesitaskliniek West   (Netherlands)

^g MÁXIMA MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GASTROINTESTINAL HORMONE; GHRELIN; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; PEPTIDE YY; GLUCOSE BLOOD LEVEL; HORMONE;

ADULT; ARTICLE; CALORIC RESTRICTION; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DETERIORATION; FEMALE; GASTRIC BANDING; GLUCOSE METABOLISM; HORMONE RELEASE; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POSTPRANDIAL STATE; PRIORITY JOURNAL; ROUX Y ANASTOMOSIS; STOMACH BYPASS; WEIGHT REDUCTION; ANALYSIS; AREA UNDER THE CURVE; BLOOD; COMPLICATION; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; INSULIN RESISTANCE; INTESTINE; MIDDLE AGED; PROCEDURES;

ADIPOSITY; AREA UNDER CURVE; BLOOD GLUCOSE; CALORIC RESTRICTION; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; GASTRIC BYPASS; GHRELIN; GLUCOSE; HORMONES; HUMANS; HYPERGLYCEMIA; INSULIN; INSULIN RESISTANCE; INTESTINES; MIDDLE AGED; OBESITY; WEIGHT LOSS;

EID: 84899586328     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12254     Document Type: Article

References (25)

1. Matthaei, S., Stumvoll, M., Kellerer, M., et al,. (2000) Pathophysiology and pharmacological treatment of insulin resistance. Endocrine Reviews, 21, 585-618.
2. Muoio, D.M., &, Newgard, C.B., (2008) Mechanisms of disease: molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. Nature Reviews Molecular Cell Biology, 9, 193-205.
3. Jazet, I.M., Pijl, H., Frolich, M., et al,. (2005) Two days of a very low calorie diet reduces endogenous glucose production in obese type 2 diabetic patients despite the withdrawal of blood glucose-lowering therapies including insulin. Metabolism, 54, 705-712.
4. Kashyap, S.R., Daud, S., Kelly, K.R., et al,. (2010) Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes. International Journal of Obesity, 34, 462-471.
5. Laferrere, B., Teixeira, J., McGinty, J., et al,. (2008) Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. Journal of Clinical Endocrinology and Metabolism, 93, 2479-2485.
6. Bose, M., Machineni, S., Olivan, B., et al,. (2010) Superior appetite hormone profile after equivalent weight loss by gastric bypass compared to gastric banding. Obesity (Silver Spring), 18, 1085-1091.
7. Buchwald, H., Estok, R., Fahrbach, K., et al,. (2009) Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. American Journal of Medicine, 122, 248-256.
8. Lam, T.K., Pocai, A., Gutierrez-Juarez, R., et al,. (2005) Hypothalamic sensing of circulating fatty acids is required for glucose homeostasis. Nature Medicine, 11, 320-327.
9. Rubino, F., Forgione, A., Cummings, D.E., et al,. (2006) The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Annals of Surgery, 244, 741-749.
10. Karra, E., &, Batterham, R.L., (2010) The role of gut hormones in the regulation of body weight and energy homeostasis. Molecular and Cellular Endocrinology, 316, 120-128.
11. Drucker, D.J., (2003) Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis. Molecular Endocrinology, 17, 161-171.
12. Nauck, M.A., (2011) Incretin-based therapies for type 2 diabetes mellitus: properties, functions, and clinical implications. American Journal of Medicine, 124 (1 Suppl), S3-S18.
13. Laferrere, B., Heshka, S., Wang, K., et al,. (2007) Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes. Diabetes Care, 30, 1709-1716.
14. Korner, J., Bessler, M., Inabnet, W., et al,. (2007) Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding. Surgery for Obesity and Related Diseases, 3, 597-601.
15. Kojima, M., Hosoda, H., Date, Y., et al,. (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature, 402, 656-660.
16. Cummings, D.E., Weigle, D.S., Frayo, R.S., et al,. (2002) Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. New England Journal of Medicine, 346, 1623-1630.
17. Wang, P.Y., Caspi, L., Lam, C.K., et al,. (2008) Upper intestinal lipids trigger a gut-brain-liver axis to regulate glucose production. Nature, 452, 1012-1016.
18. Fried, M., Hainer, V., Basdevant, A., et al,. (2007) Inter-disciplinary European guidelines on surgery of severe obesity. International Journal of Obesity, 31, 569-577.
19. Falken, Y., Hellstrom, P.M., Holst, J.J., et al,. (2011) Changes in glucose homeostasis after Roux-en-Y gastric bypass surgery for obesity at day three, two months, and one year after surgery: role of gut peptides. Journal of Clinical Endocrinology and Metabolism, 96, 2227-2237.
20. Isbell, J.M., Tamboli, R.A., Hansen, E.N., et al,. (2010) The importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery. Diabetes Care, 33, 1438-1442.
21. Thorell, A., Nygren, J., &, Ljungqvist, O., (1999) Insulin resistance: a marker of surgical stress. Current Opinion in Clinical Nutrition and Metabolic Care, 2, 69-78.
22. Ljungqvist, O., (2010) Insulin resistance and outcomes in surgery. Journal of Clinical Endocrinology and Metabolism, 95, 4217-4219.
23. Bueter, M., Ashrafian, H., &, le Roux, C.W., (2009) Mechanisms of weight loss after gastric bypass and gastric banding. Obesity Facts, 2, 325-331.
24. Camastra, S., Gastaldelli, A., Mari, A., et al,. (2011) Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes. Diabetologia, 54, 2093-2102.
25. Campos, G.M., Rabl, C., Peeva, S., et al,. (2010) Improvement in peripheral glucose uptake after gastric bypass surgery is observed only after substantial weight loss has occurred and correlates with the magnitude of weight lost. Journal of Gastrointestinal Surgery, 14, 15-23.